CLINICAL_TRIALS
trial_result
· 2025-02-06
Clinical Trial Update: Rituximab + Immunotherapy in Follicular Lymphoma [Phase 1]
Summary
Phase 1 trial of Rituximab plus immunotherapy in follicular lymphoma was terminated. Results were posted on 2025-02-06.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Follicular Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2025-02-06